Skip to main content
x

Recent articles

Verastem spoils its ASCO bounce

An initial winner of the ASCO abstract reveal, Verastem drops a bombshell.

ASCO 2024 abstract movers – Merus convinces, at first

Thursday's unveiling of regular ASCO abstract yielded a few initial winners and losers.

ASCO 2024 preview – toxicity looms large for J&J

Four deaths cast doubt on J&J’s multi-pronged KLK2 push.

ASCO 2024 preview – jury still out on AbbVie's cancer push

SEZ6 looks promising but early, while questions remain around toxicity with AbbVie's cMet ADCs.

ASCO 2024 preview – two strikes against USP1

Tango cans TNG348 while Roche’s KSQ-4279 looks virtually inactive.

ASCO 2024 preview – new Car-T target shows liver cancer promise

Targeting GPC3 has scored a win for AstraZeneca’s Chinese partner, after Takeda drew a blank.

Recent Quick take

Most Popular